# Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents

> **NCT00921557** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 52 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Alendronate
- **DRUG:** Placebo
- **DIETARY_SUPPLEMENT:** Calcium carbonate/vitamin D

## Key facts

- **NCT ID:** NCT00921557
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2016-01
- **Final completion:** 2017-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00921557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00921557, "Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents". Retrieved via AI Analytics 2026-09-11 from https://api.ai-analytics.org/clinical/NCT00921557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*